Spectral Molecular Imaging, Inc., a wholly-owned subsidiary of Cascade Technologies, Inc., is a development-stage, medical imaging device company. Application of SMI's proprietary spectral-optical imaging technology - originally developed for satellite reconnaissance - is expected to advance the diagnoses of cancer and precancerous conditions. SMI is developing non-invasive imaging systems using its patented technology for improved clinical diagnostics, primarily in the field of cancer pathology.

SMI's devices utilize high-resolution imaging, identification, and analysis of certain molecular, cellular, and tissue features via patented spectral-imaging approaches. We also intend to provide services related to our primary products, including software modules and maintenance services, and to develop optical diagnostic products that operate in conjunction with surgical and/or evaluation procedures in real time.

Our technology is expected to enable early detection and more reliable diagnosis of various diseases, including skin cancers such as melanoma, Barrett's esophagus (a condition caused by chronic acid reflux that can lead to esophageal cancer) and lung cancer. The development of this technology is expected to significantly improve long-term patient outcomes while substantially reducing overall costs for the healthcare system. For more information, please visit http://www.spectralmi.com.

Spectral Molecular Imaging, Inc.
250 N. Robertson Blvd., Suite 427
Beverly Hills, California 90211
Phone: 310.858.1670
Fax: 310.858.1699

Spectral Molecular Imaging

Spectral Molecular Imaging Releases Investor Information Briefing on Company's Development of Advanced Devices for Cancer Detection and Other Applications (Thursday, June 14th, 2010)

Safe Harbor disclaimer: Certain statements contained herein constitute forward-looking statements within the meaning of Section 27Aof the Securities Act and Section 21E of the Exchange Act. Such statements include, without limitation, statements regarding business and financing plans, business trends and future operating revenues and expenses. Although the company believes that the statements are reasonable, it can give no assurance that such expecta- tions will prove to be correct. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate and similar expressions, or which by their nature refer to future events. The company cautions investors that any forward-looking statements made by the company are not guarantees of future performance, and that the actual results may differ materially from those in the forward-looking statements as a result of vari- ous factors, including but not limited to, the company’s ability to continue its projected growth, or to be able to fully implement its business strategies.

This profile is not without bias, and is a paid release. investingnewsalerts.com has been compensated for dissemination of company information on behalf of a third party. investingnewsalerts.com has been compensated $5,000 for coverage of this stock, by a third party, for services provided including dissemination of company information in this release. investingnewsalerts.com holds no shares of the stock. investingnewsalerts.com may receive shares for extension of its services. Any shares will be disclosed at such time that investingnewsalerts.com is aware of a clients desire to extend the original services. investingnewsalerts.com may have received shares of a company profiled in this release prior to the dissemination of the information in this release. investingnewsalerts.com may immediately sell some or any shares in a profiled company held by investingnewsalerts.com and may have previously sold shares in a profiled company held by investingnewsalerts.com. investingnewsalerts.com's services for a company may cause the company's stock price to increase, in which event investornewsalerts.com would make a profit when it sells its stock in a company. In addition, investingnewsalerts.com's selling of a company's stock may have a negative effect on the market price of the stock.

Got question, found problem? - info@investingnewsalerts.com